ID
41380
Description
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma
Keywords
Versions (2)
- 9/18/20 9/18/20 -
- 10/30/20 10/30/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 18, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162
Yearly Follow-up contact; Anti Cancer Therapy
- StudyEvent: ODM
Description
Yearly Follow-up - Check for Follow-up contact
Alias
- UMLS CUI-1
- C1522577
- UMLS CUI-2
- C0332158
Description
Yes → Date of contact No → Please complete the Death Form. Please complete the Study Conclusion Unknown → Please specify the reason
Data type
text
Alias
- UMLS CUI [1]
- C2584946
Description
If patient ist alive, enter date of contact
Data type
date
Alias
- UMLS CUI [1,1]
- C2584946
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C1705415
Description
If unknown if patient is still alive, please specify reason
Data type
text
Alias
- UMLS CUI [1]
- C2584946
- UMLS CUI [2]
- C0439673
- UMLS CUI [3,1]
- C0392360
- UMLS CUI [3,2]
- C2348235
Description
If other reason, please specify
Data type
text
Alias
- UMLS CUI [1,1]
- C3840932
- UMLS CUI [1,2]
- C2348235
Description
End of yearly Follow-up contact
Alias
- UMLS CUI-1
- C1522577
- UMLS CUI-2
- C0332158
- UMLS CUI-3
- C0444930
Description
Anti-cancer therapy(ies) following last study treatment administration
Alias
- UMLS CUI-1
- C0920425
- UMLS CUI-2
- C3469597
- UMLS CUI-3
- C0304229
- UMLS CUI-4
- C1517741
Description
Subsequent treatment
Alias
- UMLS CUI-1
- C0087111
- UMLS CUI-2
- C0332282
Description
Type of therapy
Data type
text
Alias
- UMLS CUI [1,1]
- C0332307
- UMLS CUI [1,2]
- C0087111
Description
Specify
Data type
text
Alias
- UMLS CUI [1]
- C2348235
Description
Date of First Treatment administration/ surgery
Data type
date
Alias
- UMLS CUI [1,1]
- C3469597
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0205435
- UMLS CUI [1,4]
- C0011008
- UMLS CUI [2,1]
- C0543467
- UMLS CUI [2,2]
- C0205435
- UMLS CUI [2,3]
- C0011008
Description
Date of last Treatment administration (Not applicable for surgery)
Data type
date
Alias
- UMLS CUI [1,1]
- C3469597
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C1517741
- UMLS CUI [1,4]
- C0011008
Similar models
Yearly Follow-up contact; Anti Cancer Therapy
- StudyEvent: ODM
C0332158 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
C1705415 (UMLS CUI [1,3])
C0439673 (UMLS CUI [2])
C0392360 (UMLS CUI [3,1])
C2348235 (UMLS CUI [3,2])
C2348235 (UMLS CUI [1,2])
C0332158 (UMLS CUI-2)
C0444930 (UMLS CUI-3)
C1517741 (UMLS CUI [1,2])
C0332158 (UMLS CUI [1,3])
C3469597 (UMLS CUI-2)
C0304229 (UMLS CUI-3)
C1517741 (UMLS CUI-4)
C3469597 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C1517741 (UMLS CUI [3])
C0304229 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0543467 (UMLS CUI [2,1])
C0205435 (UMLS CUI [2,2])
C0011008 (UMLS CUI [2,3])
C0304229 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])